Riskpilot← Back to searchSign inGet full accessBIOLINK INDUSTRIAL AS
ASActiveOrg 919210427Fosseikeveien 24, 4323 SandnesRental and operating of own or leased real estate · NACE 6820Est. 20170 employeeswww.biolink.no
Revenue 2025
NOK 2,9M
-5% vs 2024
EBITDA margin
96.1%
-6% vs 2024
Equity ratio
9.1%
Financial strength
Net profit 2025
NOK -680K
-33% vs 2024
| Revenue | NOK 2,9M | -5% |
| EBITDA | NOK 2,7M | -6% |
| Net profit | NOK -680K | -33% |
| Total assets | NOK 49,8M | -2% |
| Equity | NOK 4,5M | -13% |
| Employees | 0 | — |
Legal name
BIOLINK INDUSTRIAL AS
Org number
919210427
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
28. juni 2017
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Å utvikle og drifte næringseiendom og alt som dertil står i forbindelse.
Address
Fosseikeveien 24, 4323 Sandnes
Website
www.biolink.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 507 | 2 507 | 2 670 | 2 998 | 2 860 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 2 433 | 2 437 | 2 569 | 2 929 | 2 748 |
| Depreciation & amort. | −963 | −963 | −960 | −953 | −953 |
| EBIT | 1 470 | 1 474 | 1 609 | 1 976 | 1 796 |
| Net financials | −878 | −1 347 | −2 201 | −2 629 | −2 667 |
| Profit before tax | 592 | 127 | −593 | −652 | −871 |
| Tax | 130 | 28 | −130 | −141 | −192 |
| Net profit | 462 | 99 | −462 | −511 | −680 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 51 903 | 50 945 | 50 177 | 50 631 | 49 764 |
| Equity | 6 078 | 6 177 | 5 715 | 5 204 | 4 524 |
| Long-term debt | 45 493 | 44 321 | 43 290 | 44 449 | 44 348 |
| Short-term debt | 332 | 447 | 1 172 | 978 | 892 |
| Total debt | 45 825 | 44 768 | 44 462 | 45 427 | 45 240 |
EBITDA margin
96.1%
This company
15.8%
Market median
+508% vs market
20212025
Equity ratio
9.1%
This company
38.2%
Market median
-76% vs market
20212025
Return on equity
-15.0%
This company
18.4%
Market median
-182% vs market
20212025
Net profit margin
-23.8%
This company
8.1%
Market median
-394% vs market
20212025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20212025
Debt / equity
10.00×
This company
0.62×
Market median
-1513% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2025 | |
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svaboe Invest As
BIOLINK INDUSTRIAL AS Board members of BIOLINK INDUSTRIAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kåre Svaboe | Chief Executive Officer | 0 companies |
| Svein Ove Føyen | Board of Directors | 0 companies |
| Sjur Svaboe | Chairman | 0 companies |
| Linn Kathrine Høiland Sagerup | Board of Directors | 0 companies |
| Kristian Larsen | Board of Directors | 0 companies |
| Torleiv Bilstad | Board of Directors | 0 companies |